Waldemar Priebe
Keine laufenden Positionen mehr
Profil
Waldemar Priebe is the founder of Reata Pharmaceuticals, Inc. (founded in 2002), Moleculin Biotech, Inc. (founded in 2015), and CNS Pharmaceuticals, Inc. (founded in 2017).
Ehemalige bekannte Positionen von Waldemar Priebe
Unternehmen | Position | Ende |
---|---|---|
MOLECULIN BIOTECH, INC. | Gründer | - |
CNS PHARMACEUTICALS, INC. | Gründer | - |
REATA PHARMACEUTICALS, INC. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MOLECULIN BIOTECH, INC. | Health Technology |
CNS PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Reata Pharmaceuticals, Inc.
Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |